Imagine that the whole brain suffers in disease - yet only one half of it is protected by approved drugs.
Cellestial Health is a spin-off company from the University of Cambridge. We develop safe small molecule therapeutics protecting often-overlooked networks of brain cells called astrocytes to stop progression of Parkinson's and other brain disorders.
Company Details
- Employees
- 5
- Founded
- 2023
- Address
- Cambridge, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://cellestialhealth.com
- Keywords
- Parkinson's Disease, Astrocytes, Neurology.
- HQ
- Cambridge
Cellestial Health Questions
Cellestial Health's website is https://cellestialhealth.com
Cellestial Health's LinkedIn profile is https://uk.linkedin.com/company/cellestial-health
Cellestial Health has
5 employees.
View email and phone details for 5
employees at Cellestial Health.
Cellestial Health's industry is
Biotechnology Research
Cellestial Health's top competitors are
Epibone, Inc.,
Script Biosciences,
Fimmcyte,
Evoralis,
Gutsee Health,
Zinc,
Alceus Bio,
Cambridge Medixine Ltd.,
Ten30 Biosciences Inc,
Serenatis Bio.
Cellestial Health's categories are Biotechnology Research
Cellestial Health's founding year is 2023
